NCT06470542View on ClinicalTrials.gov

Two-level ESPB in Total Knee Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 7, 2024

Primary Completion Date

August 5, 2025

Study Completion Date

August 5, 2025

Conditions
Knee OsteoarthritisKnee Pain ChronicKnee Arthritis
Interventions
DRUG

2 x 20 ml of Ropivacaine 0.2% Injectable Solution

2 x 20ml 0.2% Ropivacaine - ultrasound-guided iPACK + ACB

DRUG

2 x 20ml of Ropivacaine 0.2% Injectable Solution

2 x 20ml 0.2% ropivacaine - ultrasound-guided ESPB at the L1 and S1 level

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06470542 - Two-level ESPB in Total Knee Arthroplasty | Biotech Hunter | Biotech Hunter